{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:50:05Z","timestamp":1784317805517,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10072-025-08624-7","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T22:26:10Z","timestamp":1767479170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary oculoleptomeningeal transthyretin amyloidosis with subarachnoid hemorrhages, visual loss, and heart and skin amyloid deposits"],"prefix":"10.1007","volume":"47","author":[{"given":"Alessandro","family":"Francia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Mattavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Zicarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Marucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Pareyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-8530","authenticated-orcid":false,"given":"Leonardo","family":"Pantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"24","key":"8624_CR1","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1212\/WNL.0000000000012965","volume":"97","author":"L Sousa","year":"2021","unstructured":"Sousa L, Coelho T, Taipa R (2021) CNS involvement in hereditary transthyretin amyloidosis. Neurology 97(24):1111\u20131119. https:\/\/doi.org\/10.1212\/WNL.0000000000012965","journal-title":"Neurology"},{"issue":"7","key":"8624_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/01.wnl.0000178983.20975.af","volume":"65","author":"M Nakamura","year":"2005","unstructured":"Nakamura M, Yamashita T, Ueda M et al (2005) Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Neurology 65(7):1051\u20131056. https:\/\/doi.org\/10.1212\/01.wnl.0000178983.20975.af","journal-title":"Neurology"},{"issue":"3","key":"8624_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/01.TP.0000111516.60013.E6","volume":"77","author":"Y Ando","year":"2004","unstructured":"Ando Y, Terazaki H, Nakamura M et al (2004) A different amyloid formation mechanism: de Novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 77(3):345\u2013349. https:\/\/doi.org\/10.1097\/01.TP.0000111516.60013.E6","journal-title":"Transplantation"},{"issue":"7","key":"8624_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/genes12070955","volume":"12","author":"AM Minnella","year":"2021","unstructured":"Minnella AM, Rissotto R, Antoniazzi E et al (2021) Ocular involvement in hereditary amyloidosis. Genes 12(7):955. https:\/\/doi.org\/10.3390\/genes12070955","journal-title":"Genes"},{"issue":"4","key":"8624_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/13506129.2012.724035","volume":"19","author":"J Levy","year":"2012","unstructured":"Levy J, Hawkins PN, Rowczenio D, Godfrey T, Stawell R, Zamir E (2012) Familial amyloid polyneuropathy associated with the novel transthyretin variant Arg34Gly. Amyloid 19(4):201\u2013203. https:\/\/doi.org\/10.3109\/13506129.2012.724035","journal-title":"Amyloid"},{"key":"8624_CR6","doi-asserted-by":"publisher","unstructured":"Shi Y, Li J, Hu J, Hu J, Sun L, Li H, Shi R, Yang L, Sun Y, Li C (2011) A new Arg54Gly transthyretin gene mutation associated with vitreous amyloidosis in Chinese. Eye Sci 26(4):230-8. https:\/\/doi.org\/10.3969\/j.issn.1000-4432.2011.04.010","DOI":"10.3969\/j.issn.1000-4432.2011.04.010"},{"issue":"5","key":"8624_CR7","doi-asserted-by":"publisher","first-page":"e200013","DOI":"10.1212\/NXG.0000000000200013","volume":"8","author":"M Tzagournissakis","year":"2022","unstructured":"Tzagournissakis M, Foukarakis E, Samonakis D et al (2022) High hereditary Transthyretin-Related amyloidosis prevalence in Crete. Neurol Genet 8(5):e200013. https:\/\/doi.org\/10.1212\/NXG.0000000000200013","journal-title":"Neurol Genet"},{"issue":"6","key":"8624_CR8","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F et al (2005) Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 46(6):1076\u20131084. https:\/\/doi.org\/10.1016\/j.jacc.2005.05.073","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"8624_CR9","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.015","volume":"24","author":"F Salvi","year":"2015","unstructured":"Salvi F, Pastorelli F, Plasmati R et al (2015) Brain microbleeds 12 years after orthotopic liver transplantation in Val30Met amyloidosis. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 24(6):e149\u2013151. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.02.015","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"key":"8624_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2014-308107","volume":"86","author":"LF Maia","year":"2015","unstructured":"Maia LF, Magalh\u00e3es R, Freitas J et al (2015) CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. J Neurol Neurosurg Psychiatry 86:159\u2013167","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"8624_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jamaneurol.2023.5762","volume":"81","author":"T Nomura","year":"2024","unstructured":"Nomura T, Misumi Y, Tasaki M et al (2024) Origin of transthyretin in cerebral amyloid angiopathy. JAMA Neurol 81(4):421\u2013423. https:\/\/doi.org\/10.1001\/jamaneurol.2023.5762","journal-title":"JAMA Neurol"},{"issue":"8","key":"8624_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"Charidimou A, Boulouis G, Frosch MP et al (2022) The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI\u2013neuropathology diagnostic accuracy study. Lancet Neurol 21(8):714\u2013725. https:\/\/doi.org\/10.1016\/S1474-4422(22)00208-3","journal-title":"Lancet Neurol"},{"issue":"3","key":"8624_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/13506129.2023.2167595","volume":"30","author":"FJ Tsai","year":"2023","unstructured":"Tsai FJ, Jaeger M, Coelho T, Powers ET, Kelly JW (2023) Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis 30(3):279\u2013289. https:\/\/doi.org\/10.1080\/13506129.2023.2167595","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"8624_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/febs.15339","volume":"288","author":"F Pinheiro","year":"2021","unstructured":"Pinheiro F, Varej\u2009~\u2009ao N, Esperante S et al (2021) Tolcapone, a potent aggregation inhibitor for the treatment of Familial leptomeningeal amyloidosis. FEBS J 288:310\u2013324. https:\/\/doi.org\/10.1111\/febs.15339","journal-title":"FEBS J"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08624-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08624-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08624-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:04:29Z","timestamp":1773072269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08624-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["8624"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08624-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LP receive small consultancy fees from Amicus, Medtronic, and PIAM. He serves in the editorial board of Neurology, European Stroke Journal, Cerebrovascular Diseases, Cerebral Circulation Cognition and Behavior and is associated editor of Neurological Sciences. DP has served on advisory boards for Inflectis, Alnylam, Akcea, Arvinas, Augustine Tx, DTx and Novartis, has received speaker's honorarium from Alnylam and AstraZeneca and is associate editor of Neurological Sciences and Journal of Neuromuscular Disorders. The other authors report no disclosures relevant to the manuscript. SF and DP are members of the EURO NMD European Reference Network.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"93"}}